Structures by: Ravikumar K.
Total: 373
4-(4-{3-[4-chloro-3-(trifluoromethyl)phenyl]ureido}phenoxy)- <i>N</i>-methylpyridine-2-carboxamide
C21H16ClF3N4O3
Acta Crystallographica Section C (2011) 67, 1 o29-o32
a=8.1587(16)Å b=9.8055(19)Å c=27.758(5)Å
α=90.00° β=94.358(3)° γ=90.00°
4-(4-{3-[4-chloro-3-(trifluoromethyl)phenyl]ureido}phenoxy)-2-(<i>N</i>- methylcarbamoyl)pyridinium 4-methylbenzenesulfonate
C21H17ClF3N4O3,C7H7O3S
Acta Crystallographica Section C (2011) 67, 1 o29-o32
a=21.276(4)Å b=9.1160(17)Å c=16.077(3)Å
α=90.00° β=108.143(3)° γ=90.00°
(2<i>R</i>,3<i>S</i>)-3-(3-hydroxyphenyl)- <i>N</i>,<i>N</i>,2-trimethylpentan-1-aminium chloride
C14H24NO,Cl
Acta Crystallographica Section C (2011) 67, 2 o71-o76
a=8.8218(6)Å b=12.1304(8)Å c=14.0031(9)Å
α=90.00° β=90.00° γ=90.00°
(2<i>S</i>,3<i>R</i>)-3-(3-hydroxyphenyl)- <i>N</i>,<i>N</i>,2-trimethylpentan-1-aminium chloride
C14H24NO,Cl
Acta Crystallographica Section C (2011) 67, 2 o71-o76
a=8.8101(6)Å b=12.1094(8)Å c=13.9784(9)Å
α=90.00° β=90.00° γ=90.00°
(2<i>R</i>,3<i>R</i>)-3-(3-hydroxyphenyl)- <i>N</i>,<i>N</i>,2-trimethylpentan-1-aminium chloride
C14H24NO,Cl
Acta Crystallographica Section C (2011) 67, 2 o71-o76
a=7.1600(15)Å b=11.688(3)Å c=17.514(4)Å
α=90.00° β=94.535(3)° γ=90.00°
(2<i>S</i>,3<i>S</i>)-3-(3-hydroxyphenyl)- <i>N</i>,<i>N</i>,2-trimethylpentan-1-aminium chloride
C14H24NO,Cl
Acta Crystallographica Section C (2011) 67, 2 o71-o76
a=7.160(3)Å b=11.688(5)Å c=17.526(8)Å
α=90.00° β=94.570(7)° γ=90.00°
Cytosinium zoledronate trihydrate
C4H6N3O,C5H9N2O7P2,3(H2O)
Acta Crystallographica Section C (2011) 67, 3 o115-o119
a=6.7292(16)Å b=6.8032(16)Å c=19.193(5)Å
α=89.875(4)° β=86.747(5)° γ=84.726(4)°
Bis(adeninium) zoldronate tetrahydrate
2(C5H6N5),C5H8N2O7P22,4(H2O)
Acta Crystallographica Section C (2014) 70, 1 67-74
a=7.2128(7)Å b=17.7448(17)Å c=19.3945(18)Å
α=90.00° β=93.999(2)° γ=90.00°
Bis(adeninium) zoldronate hexahydrate
2(C5H6N5),C5H8N2O7P22,6(H2O)
Acta Crystallographica Section C (2014) 70, 1 67-74
a=7.2742(6)Å b=10.7987(9)Å c=17.6202(15)Å
α=102.3800(10)° β=94.2540(10)° γ=93.2230(10)°
9-Chloro-8-fluoro-4-phenyl-2,3,3a,4,5,9b-hexahydrofuro[3,2-c]quinoline
C17H15ClFNO
Acta Crystallographica Section C (2004) 60, 12 o887-o889
a=17.0056(17)Å b=10.7527(11)Å c=15.7079(16)Å
α=90.00° β=99.367(2)° γ=90.00°
9-Chloro-8-fluoro-4-phenyl-2,3,3a,4,5,9b-hexahydrofuro[3,2-c]quinoline
C17H15ClFNO
Acta Crystallographica Section C (2004) 60, 12 o887-o889
a=8.1796(6)Å b=17.9041(12)Å c=9.6562(7)Å
α=90.00° β=91.0170(10)° γ=90.00°
4<i>H</i>-1,2,4-Triazolo[3,4-<i>c</i>][1,4]benzothiazin-1(2<i>H</i>)-one
C9H7N3OS
Acta Crystallographica Section C (2012) 68, 11 o475-o480
a=14.6307(11)Å b=8.5718(7)Å c=28.083(2)Å
α=90.00° β=90.00° γ=90.00°
2-(2-Oxo-2-phenylethyl)-4<i>H</i>-1,2,4-triazolo[3,4- <i>c</i>][1,4]benzothiazin-1(2<i>H</i>)-one
C17H13N3O2S
Acta Crystallographica Section C (2012) 68, 11 o475-o480
a=11.6248(18)Å b=14.920(2)Å c=8.5909(13)Å
α=90.00° β=102.564(3)° γ=90.00°
Ethyl 3-oxo-2-(1-oxo-1<i>H</i>,4<i>H</i>-1,2,4-triazolo[3,4- <i>c</i>][1,4]benzothiazin-2-yl)-3-phenylpropanoate
C20H17N3O4S
Acta Crystallographica Section C (2012) 68, 11 o475-o480
a=13.6533(14)Å b=12.7279(13)Å c=22.2927(19)Å
α=90.00° β=100.601(3)° γ=90.00°
6-methyl-5-(N-methylcarbamoyl)-4-phenyl-1,2,3,4-dihydropyrimidine-2-thione monohydrate
C13H15N3OS,H2O
Acta Crystallographica Section C (2005) 61, 1 o41-o44
a=5.0116(3)Å b=8.9507(6)Å c=16.0882(11)Å
α=86.0950(10)° β=84.8410(10)° γ=78.2410(10)°
4-(4-chlorophenyl)-6-methyl-5-(N-methylcarbamoyl)-1,2,3,4-dihydropyrimidine- 2-thione monohydrate
C13H14ClN3OS,H2O
Acta Crystallographica Section C (2005) 61, 1 o41-o44
a=4.8853(3)Å b=9.7093(7)Å c=16.0343(11)Å
α=79.5060(10)° β=84.7920(10)° γ=82.8340(10)°
8-chloro-9-fluoro-5-phenyl-3,4,4a,5,6,10b-hexahydro-2H-pyrano[3,2-c]quinoline
C18H17ClFNO
Acta Crystallographica Section C (2005) 61, 5 o267-o269
a=10.5399(7)Å b=11.2005(7)Å c=13.4950(9)Å
α=82.5970(10)° β=83.8900(10)° γ=80.8840(10)°
10-chloro-9-fluoro-5-phenyl-3,4,4a,5,6,10b-hexahydro-2H-pyrano[3,2-c]quinoline
C18H17ClFNO
Acta Crystallographica Section C (2005) 61, 5 o267-o269
a=8.3032(8)Å b=10.5190(11)Å c=18.1165(18)Å
α=104.234(2)° β=92.309(2)° γ=91.783(2)°
4-[2-(dipropylamino)ethyl]-2,3-dihydro-1H-indol-2-ol hydrochloride
C16H25N2O,Cl
Acta Crystallographica Section C (2006) 62, 5 o265-o267
a=7.5388(11)Å b=8.9545(13)Å c=12.1647(18)Å
α=80.005(2)° β=85.968(2)° γ=83.504(2)°
Adeninium phenylacetate phenylacetic acid hydrate
C5H6N5,C8H7O2,C8H8O2,H2O
Acta Crystallographica Section C (2007) 63, 7 o415-o418
a=4.7805(10)Å b=10.303(2)Å c=21.678(5)Å
α=88.886(4)° β=87.595(3)° γ=83.239(4)°
Adeninium succinate hydrate
C5H6N5,C4H3O4,H2O
Acta Crystallographica Section C (2007) 63, 7 o415-o418
a=9.539(3)Å b=17.149(6)Å c=7.450(3)Å
α=90.00° β=100.503(5)° γ=90.00°
(<i>S</i>)-4-{3-[2-(dimethylamino)ethyl]-1<i>H</i>-indol-5- ylmethyl}oxazolidin-2-one benzene solvate
C16H21N3O2,C6H6
Acta Crystallographica Section C (2007) 63, 7 o437-o440
a=8.6938(5)Å b=12.1331(7)Å c=19.5321(12)Å
α=90.00° β=90.00° γ=90.00°
(<i>S</i>)-4-{3-[2-(dimethylamino)ethyl]-1<i>H</i>-indol-5- ylmethyl}oxazolidin-2-one phenol solvate
C16H21N3O2,C6H6O
Acta Crystallographica Section C (2007) 63, 7 o437-o440
a=8.7618(13)Å b=19.506(3)Å c=12.1767(18)Å
α=90.00° β=91.399(2)° γ=90.00°
(2<i>S</i>,4<i>R</i>)-2-(<i>N</i>-{(1<i>S</i>,2<i>S</i>)-2-chloro-1- [(3<i>R</i>,4<i>S</i>,5<i>R</i>,6<i>R</i>)-3,4,5-trihydroxy-6- (methylsulfanyl)perhydropyran-2-yl]propyl}aminocarbonyl)-4-propylpyrrolidinium chloride monohydrate
C18H34ClN2O5S,Cl,H2O
Acta Crystallographica Section C (2010) 66, 2 o97-o100
a=9.4669(6)Å b=9.9255(6)Å c=13.4949(8)Å
α=90.00° β=104.6010(10)° γ=90.00°
(2<i>S</i>,4<i>R</i>)-2-(<i>N</i>-{(1<i>S</i>,2<i>S</i>)-2-chloro-1- [(3<i>R</i>,4<i>S</i>,5<i>R</i>,6<i>R</i>)-3,4,5-trihydroxy-6- (methylsulfanyl)perhydropyran-2-yl]propyl}aminocarbonyl)-4-propylpyrrolidinium chloride monohydrate ethanol solvate
C18H34ClN2O5S,Cl,H2O,C2H6O
Acta Crystallographica Section C (2010) 66, 2 o97-o100
a=9.9630(16)Å b=10.6998(17)Å c=26.324(4)Å
α=90.00° β=90.00° γ=90.00°
Bis(frovatriptan) succinate trihydrate
2(C14H18N3O),C4H4O42,3(H2O)
Acta Crystallographica Section C (2013) 69, 4 428-435
a=8.7239(11)Å b=18.662(2)Å c=10.1270(13)Å
α=90.00° β=96.098(2)° γ=90.00°
Frovatriptan acetate
C14H18N3O,C2H3O2
Acta Crystallographica Section C (2013) 69, 4 428-435
a=11.2397(8)Å b=16.7124(13)Å c=8.6528(6)Å
α=90.00° β=96.1500(10)° γ=90.00°
Eletriptan hydrobromide monohydrate
C22H27N2O2S,Br,H2O
Acta Crystallographica Section C (2008) 64, 12 o653-o656
a=9.4019(6)Å b=13.4089(8)Å c=18.0173(11)Å
α=90.00° β=90.00° γ=90.00°
Naratriptan hydrochloride
C17H26N3O2S,Cl
Acta Crystallographica Section C (2008) 64, 12 o653-o656
a=6.1914(5)Å b=12.2298(10)Å c=12.9948(11)Å
α=78.3480(10)° β=76.3380(10)° γ=86.0330(10)°
Lapatinb monotosylate
C29H27ClFN4O4S,C7H7O3S
Acta Crystallographica Section C (2013) 69, 12 1516-1523
a=5.7828(4)Å b=20.7395(14)Å c=29.4867(19)Å
α=90.00° β=90.00° γ=90.00°
Lapatinib ditosylate
C29H28ClFN4O4S2,2(C7H7O3S)
Acta Crystallographica Section C (2013) 69, 12 1516-1523
a=9.2122(6)Å b=13.2387(9)Å c=18.3758(12)Å
α=95.3870(10)° β=92.4630(10)° γ=100.3590(10)°
C26H29N1O7
C26H29N1O7
Acta Crystallographica Section C Crystal Structure Communications (1995) 51, 3 426
a=6.937(2)Å b=15.320(2)Å c=23.423(3)Å
α=90.° β=90.° γ=90.°
Lamotrigine
C9H7Cl2N5
Acta Crystallographica Section C (2009) 65, 9 o460-o464
a=19.136(3)Å b=8.6409(12)Å c=13.5549(18)Å
α=90.00° β=109.172(2)° γ=90.00°
Lamotriginium chloride
C9H8Cl2N5,Cl
Acta Crystallographica Section C (2009) 65, 9 o460-o464
a=16.664(5)Å b=5.5139(17)Å c=13.392(4)Å
α=90.00° β=102.588(5)° γ=90.00°
Lamotriginium nitrate
C9H8Cl2N5,NO3
Acta Crystallographica Section C (2009) 65, 9 o460-o464
a=7.1356(9)Å b=13.3711(17)Å c=14.0294(18)Å
α=88.285(2)° β=85.502(2)° γ=75.516(2)°
Safinamide
C17H19FN2O2
Acta Crystallographica Section C (2010) 66, 6 o317-o320
a=5.1127(5)Å b=17.8516(16)Å c=17.87460(10)Å
α=90.00° β=90.00° γ=90.00°
Safinamide
C17H19FN2O2
Acta Crystallographica Section C (2010) 66, 6 o317-o320
a=6.6297(9)Å b=8.1015(12)Å c=29.268(4)Å
α=90.00° β=90.00° γ=90.00°
(4S)-trans-4-ethylammonio-5,6-dihydro-6-methyl-4H-thieno[2,3-b]thiopyran- 2-sulfonamide 7,7-dioxide chloride
C10H17N2O4S3,Cl
Acta Crystallographica Section C (2007) 63, 2 o108-o110
a=8.1272(6)Å b=10.0646(8)Å c=18.2504(14)Å
α=90.00° β=90.00° γ=90.00°
Cytosinium nicotinate hydrate
C4H6N3O,C6H4NO2,H2O
Acta Crystallographica Section C (2010) 66, 8 o414-o417
a=7.5314(5)Å b=18.2710(12)Å c=8.4249(6)Å
α=90.00° β=104.3740(10)° γ=90.00°
Cytosinium isonicotinate cytosine dihydrate
C4H6N3O,C6H4NO2,C4H5N3O,2H2O
Acta Crystallographica Section C (2010) 66, 8 o414-o417
a=7.1852(8)Å b=7.3627(8)Å c=17.7387(18)Å
α=99.831(2)° β=92.928(2)° γ=107.862(2)°
Moxifloxacin hydrochloride
C21H25FN3O4,Cl,0.5H2O,0.5CH4O
Acta Crystallographica Section C (2006) 62, 8 o478-o482
a=6.828(2)Å b=20.929(6)Å c=15.357(5)Å
α=90.00° β=92.007(5)° γ=90.00°
5,3'-dihydroxy-3,6,7,4',5'-pentamethoxyflavone
C20H20O9
Acta Crystallographica Section C (2006) 62, 8 o495-o497
a=7.5629(5)Å b=15.2199(9)Å c=17.6543(11)Å
α=69.6210(10)° β=83.1450(10)° γ=77.7600(10)°
9-fluoro-5-phenyl-3,4,4a,5,6,10b-hexahydro-2H-pyrano[3,2-c]quinoline
C18H18FNO
Acta Crystallographica Section C (2006) 62, 9 o574-o576
a=8.3005(9)Å b=9.6401(11)Å c=10.0400(11)Å
α=66.154(2)° β=79.666(2)° γ=79.880(2)°
(+-)-2-(4-methoxyphenyl)-1-phenethyl-2,3-dihydroquinazolin-4(1H)-one
C23H22N2O2
Acta Crystallographica Section C (2008) 64, 2 o80-o83
a=6.7224(15)Å b=10.326(2)Å c=14.694(3)Å
α=109.331(4)° β=100.233(4)° γ=90.803(4)°
(+-)-2-(1,3-benzodioxol-5-yl))-1-phenethyl-2,3-dihydroquinazolin-4(1H)-one
C23H20N2O3
Acta Crystallographica Section C (2008) 64, 2 o80-o83
a=29.840(5)Å b=6.6467(10)Å c=20.587(3)Å
α=90.00° β=109.529(2)° γ=90.00°
Phthalimido-3-iodo propane
C11H10INO2
Acta Crystallographica Section C (2000) 56, 7 e298-e299
a=7.5820(10)Å b=19.190(3)Å c=8.1430(10)Å
α=90.00° β=109.950(10)° γ=90.00°
Almotriptan
C17H25N3O2S
Acta Crystallographica Section C (2008) 64, 1 o15-o17
a=20.5023(17)Å b=7.6894(6)Å c=22.8470(19)Å
α=90.00° β=104.904(2)° γ=90.00°
Almotriptan Malate
C17H26N3O2S,C4H5O5
Acta Crystallographica Section C (2008) 64, 1 o15-o17
a=7.5542(7)Å b=9.3561(9)Å c=17.3608(17)Å
α=104.081(2)° β=101.121(2)° γ=92.681(2)°
Cytosinium succinate
C4H6N3O,C4H5O4
Acta Crystallographica Section C (2008) 64, 10 o566-o569
a=15.666(3)Å b=6.6959(9)Å c=18.726(3)Å
α=90.00° β=100.480(4)° γ=90.00°
Cytosinium 4-nitrobenzoate cytosine monohydrate
C4H6N3O,C7H4NO4,C4H5N3O,H2O
Acta Crystallographica Section C (2008) 64, 10 o566-o569
a=6.7154(14)Å b=7.4036(16)Å c=19.228(4)Å
α=85.525(4)° β=87.576(4)° γ=67.279(3)°
Zolmitriptan hydrogen oxalate
C16H22N3O2,C2HO4
Acta Crystallographica Section C (2013) 69, 10 1186-1191
a=5.5944(4)Å b=17.9908(14)Å c=18.3844(15)Å
α=90.00° β=92.2200(10)° γ=90.00°
Zolmitriptan camphor sulfonate
C16H22N3O2,C10H15O4S
Acta Crystallographica Section C (2013) 69, 10 1186-1191
a=9.5992(15)Å b=16.361(3)Å c=16.927(2)Å
α=90.00° β=90.00° γ=90.00°
Lamotriginium 4-methylbenzoate <i>N</i>,<i>N</i>-dimethylformamide monosolvate
C9H7.41Cl2N5,C8H7.59O2,C3H7NO
Acta Crystallographica Section C (2013) 69, 10 1164-1169
a=9.3976(12)Å b=24.904(3)Å c=10.2105(14)Å
α=90.00° β=108.976(3)° γ=90.00°
Lamotriginium 4-iodobenzoate <i>N</i>,<i>N</i>-dimethylformamide monosolvate
C9H7.54Cl2N5,C7H4.46IO2,C3H7NO
Acta Crystallographica Section C (2013) 69, 10 1164-1169
a=9.7282(6)Å b=24.9148(16)Å c=10.0307(6)Å
α=90.00° β=108.6180(10)° γ=90.00°
Lamotriginium 3,5-dinitro-2-hydroxybenzoate <i>N</i>,<i>N</i>-dimethylformamide monosolvate
C9H8Cl2N5,C7H3N2O7,C3H7NO
Acta Crystallographica Section C (2013) 69, 10 1164-1169
a=10.0227(5)Å b=10.5507(5)Å c=12.5359(6)Å
α=81.8580(10)° β=71.8880(10)° γ=70.0090(10)°
Darifenacin hydrobromide
C28H31N2O2,Br
Acta Crystallographica Section E (2009) 65, 6 o1286
a=10.2632(7)Å b=10.9525(8)Å c=21.7459(16)Å
α=90.00° β=90.00° γ=90.00°
Methyl 4-phenyl-1,2,3,3a,4,4a,5,12c- octahydronaphtho[1',2':3,2]furo[5,4-<i>b</i>]pyrrolizine-4a-carboxylate
C26H25NO3
Acta Crystallographica Section E (2010) 66, 6 o1345
a=15.0117(12)Å b=13.3421(11)Å c=20.0242(16)Å
α=90.00° β=90.00° γ=90.00°
Methyl 3-[(1<i>H</i>-benzimidazol-1-yl)methyl]-1-methyl-4-(4-methylphenyl)-2'- oxopyrrolidine-2-spiro-3'-1-benzimidazole-3-carboxylate
C29H28N4O3
Acta Crystallographica Section E (2010) 66, 10 o2508-o2509
a=9.7605(5)Å b=11.2823(6)Å c=12.2333(7)Å
α=79.9600(10)° β=69.5390(10)° γ=85.3580(10)°
1'-Methyl-4'-(1-naphthyl)-1'',2'',3'',4''-tetrahydroindane-2-spiro-2'- pyrrolidine-3'-spiro-2''-naphthalene-1,3,1''-trione
C32H25NO3
Acta Crystallographica Section E (2011) 67, 3 o629
a=10.8442(9)Å b=11.4310(10)Å c=19.2701(16)Å
α=90.00° β=90.00° γ=90.00°
Methyl 2-(2,2,4-trimethyl-6-tosylperhydro-1,3- dioxino[5,4-<i>c</i>]pyridin-5-yl)acetate
C20H29NO6S
Acta Crystallographica Section E (2009) 65, 5 o1091
a=8.2379(16)Å b=18.039(4)Å c=28.844(6)Å
α=90.00° β=90.00° γ=90.00°
Methyl 4-(4-chlorophenyl)-3,3a,4,4a,5,12c-hexahydro-2- thianaphtho[1',2':3,2]furo[5,4-<i>b</i>]pyrrolizine-4a-carboxylate
C25H22ClNO3S
Acta Crystallographica Section E (2010) 66, 8 o2098
a=8.0740(6)Å b=12.1109(8)Å c=22.1813(15)Å
α=90.00° β=90.00° γ=90.00°
1',1''-Dimethyl-4'-(naphthalen-1-yl)-1,2,3,4-tetrahydronaphthalene- 2-spiro-3'-pyrrolidine-2'-spiro-3''-indoline-1,2''-dione
C32H28N2O2
Acta Crystallographica Section E (2011) 67, 4 o751
a=8.7529(8)Å b=18.0411(16)Å c=15.4489(13)Å
α=90.00° β=98.181(2)° γ=90.00°
2-[(Ferrocen-1-yl)(hydroxy)methyl]prop-2-enenitrile
C14H13FeNO
Acta Crystallographica Section E (2013) 69, 12 m669
a=7.4317(15)Å b=8.0137(16)Å c=10.083(2)Å
α=92.09(3)° β=93.81(3)° γ=101.09(3)°
4-[(<i>E</i>)-(Hydroxyimino)methyl]-<i>N</i>,<i>N</i>-dimethylanilinium chloride
C9H13N2O,Cl
Acta Crystallographica Section E (2012) 68, 6 o1705
a=11.2696(10)Å b=11.7093(10)Å c=7.6961(7)Å
α=90.00° β=90.108(2)° γ=90.00°
C19H30N4O4,H2O
C19H30N4O4,H2O
Journal of Organic Chemistry (2004) 69, 2181-2184
a=9.7224(8)Å b=10.4293(9)Å c=10.3489(9)Å
α=90.00° β=104.695(2)° γ=90.00°
C29H26N2O3
C29H26N2O3
Journal of Organic Chemistry (2013) 78, 8624-8633
a=6.0699(14)Å b=22.271(5)Å c=17.599(4)Å
α=90.00° β=98.522(4)° γ=90.00°
C29H26N2O3
C29H26N2O3
Journal of Organic Chemistry (2013) 78, 8624-8633
a=9.0240(14)Å b=12.5680(10)Å c=21.3520(17)Å
α=90.00° β=104.171(1)° γ=90.00°
1,3-Bis(9H-carbazol-9-yl)-2-methylenepropane
C28H22N2
CrystEngComm (2011) 13, 6 2039
a=9.3786(17)Å b=23.547(4)Å c=18.543(3)Å
α=90.00° β=90.617(3)° γ=90.00°
1-Benzoyl-acenaphthylene-1-spiro-3'-pyrrolizidine-2'-spiro-3''- 1H-indole-2,2''(1H,3''H)-dione
C32H23ClN2O3
Acta Crystallographica Section E (2004) 60, 1 o57-o59
a=11.5085(9)Å b=9.5986(8)Å c=23.0306(18)Å
α=90.00° β=91.2320(10)° γ=90.00°
(2R,3aR,4S,6aR,7aR)-cis-4-Benzyl-2-(4-bromophenyl)-5-(4- methylphenylsulfonyl)perhydrothiazolidino[3,4-a]pyrrolo[4,5-c]pyrrole
C28H29BrN2O2S2
Acta Crystallographica Section E (2007) 63, 5 o2213-o2215
a=14.7207(8)Å b=9.1692(5)Å c=20.6819(11)Å
α=90.00° β=109.4610(10)° γ=90.00°
Methyl 2-{3-[(<i>tert</i>-butoxycarbonyl)amino]-1-methyl-2-oxoindolin-3-yl}-2-ethoxy-2-phenylacetate
C25H30N2O6
Acta Crystallographica Section C (2015) 71, 4 322-329
a=11.2274(14)Å b=13.3892(17)Å c=16.849(2)Å
α=91.475(2)° β=92.646(2)° γ=106.889(2)°
Frovatriptan succinate monohydrate
C14H18N3O,C4H5O4,H2O
Acta Crystallographica Section C (2013) 69, 4 428-435
a=10.6206(6)Å b=7.9939(5)Å c=22.3916(13)Å
α=90.00° β=92.8840(10)° γ=90.00°
9-methyl-5-phenyl-3,4,4a,5,6,10b-hexahydro-2H-pyrano[3,2-c]quinoline
C19H21NO
Acta Crystallographica Section C (2006) 62, 9 o574-o576
a=8.2596(7)Å b=10.0084(9)Å c=10.1134(9)Å
α=66.4350(10)° β=81.927(2)° γ=77.1410(10)°